Healthcare Economist December 4, 2022
There was much hope that the advent of the Human Genome Project would lead to significant innovations as we began to learn more and more about how genes relate to disease. The ability of translating this knowledge to targeted therapies, however, is challenging. One key issue is how many genetic mutations cause a disease; it is likely easier to create a precision medicine for a disease caused by one genetic mutation than a disease caused by multiple mutations.
In fact, this is what a paper by Hermosilla and Lemus (2018) find. They use data from the open-source Genome-Wide Association Studies (GWAS) Catalog to determine the number of genetic mutations associated...
Today's Sponsors
Today's Sponsor